Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
Our Collagen Peptides are designed to dissolve instantly in any liquid, hot or cold, making them easy to incorporate whether youre at home or using our convenient travel packs on a mountain top
Seven-day continuous infusion of IGF-1 LR3 in guinea pigs significantly increased the fractional weight of adrenals, gut, kidneys, and spleen compared to controls, indicating tissue growth effects
M.NieuwdorpM.van RaalteD
Presented for research literature review only Wang SP et al